An immunoassay with bovine serum albumin coupled peptides for the improved detection of anti V3 antibodies in HIV-1 positive human sera (Q47970652)

7 February 2018

title

An immunoassay with bovine serum albumin coupled peptides for the improved detection of anti V3 antibodies in HIV-1 positive human sera (English)

1 reference

7 February 2018

author

Carmen E Gómez

series ordinal

1

1 reference

7 February 2018

author name string

López-Campistrous AE

series ordinal

2

1 reference

7 February 2018

Duarte CA

series ordinal

3

1 reference

7 February 2018

publication date

1 March 1998

1 reference

7 February 2018

Journal of Virological Methods

published in

1 reference

7 February 2018

volume

71

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

7-16

1 reference

7 February 2018

High antigenic cross-reactivity of the V3 consensus sequences of HIV-1 gp120.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Multiepitope polypeptide of the HIV-1 envelope induces neutralizing monoclonal antibodies against V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Epitope mapping, V-region DNA sequence, and neutralizing Fab fragments of two monoclonal antibodies against the HIV-1 V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

HIV preventive vaccines. Progress to date

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Monoclonal antibody binding to peptide epitopes conjugated to synthetic branched chain polypeptide carriers. Influence of the carrier upon antibody recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Continuity and discontinuity in the anti-V3 IgG response of human immunodeficiency virus type 1-infected persons in a cross-sectional and longitudinal study using synthetic peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

The reactivities of HIV-1+ human sera with solid-phase V3 loop peptides can be poor predictors of their reactivities with V3 loops on native gp120 molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Antibody Responses of Chimpanzees Immunized with Synthetic Peptides Corresponding to Full-Length V3 Hypervariable Loops of HIV-1 Envelope Glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Measurement of antibody binding to antigenic peptides conjugated in situ to albumin-coated microtitre plates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2897%2900196-1

7 January 2021

10.1016/S0166-0934(97)00196-1

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018